Atlas Trials

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma

Clinical trial NCT00019448 · COMPLETED

Trial details

NCT number
NCT00019448
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Stage IV MelanomaRecurrent Melanoma
Start date
1998-09-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.